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Abstract 
A cDNA encoding rat H+-coupled peptide transporter PEPT2 was isolated. The cDNA encoded a protein of 729 amino acids with 
48% amino acid identity to the rat PEPT1. The mRNA expression of rat PEPT2 was predominant in the kidney. When expressed in
Xenopus oocytes, rat PEPT2 stimulated the uptake of bestatin, adipeptide-like drug. 
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Peptide transporter functionally characterized in the 
small intestine and the renal proximal tubule has been 
considered to play a key role in the maintenance of protein 
nutrition. In addition to efficient absorption of small pep- 
tides in these tissues, the peptide transporter has been 
demonstrated to mediate both the intestinal absorption 
[1-5] and the renal tubular eabsorption [6,7] of oral active 
fl-lactam antibiotics [1-6] and bestatin [7], a dipeptide-like 
anticancer drug, implying that this transporter plays a 
pharmacologically important role in chemotherapy. Studies 
using brush-border membrane vesicles isolated from these 
tissues revealed that the transporter is an electrogenic 
H*-coupled transport system specific for di- and tripep- 
tides [8-10]. However, unlike the peptide transport in the 
intestine, it has been reported that there are at least two 
distinct peptide transporters in the brush-border mem- 
branes of the renal proximal tubules [11-13]. Recently, 
cDNA encoding an oligopeptide transporter (PEPT1) ex- 
pressed in the rabbit small intestine was isolated by Xeno- 
pus oocyte expression system [14]. Using PCR technique 
based on the amino acid sequence of rabbit PEPT1, we 
also isolated cDNA encoding a rat H*/peptide cotrans- 
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porter (PEPT1) mediating absorption of fl-lactam antibi- 
otics in the small intestine and the kidney proximal tubule 
[15]. We report here the isolation of a full cDNA of the rat 
H+-coupled peptide transporter PEPT2, its functional ex- 
pression and tissue distribution. 
Total RNA was extracted from several tissues of adult 
male rats using the guanidine/isothiocyanate m thod 
[16]. Poly(A)+RNA was purified by oligo(dT)-cellulose 
(Collaborative Research, Bedford, MA) affinity column 
chromatography [17]. Degenerate PCR primers were 
designed and synthesized chemically based on the amino 
acid sequence of rabbit PEPTI: sense strand with 
SalI site, 5'-CCGTCGACTT(T/C)TT(T/C)AT(T/C)GT- 
NGTNAA-Y (corresponding to amino acid sequence 17- 
22); antisense strand with NotI site, 5'-CCGCGGCCG- 
CAC(A/ G)CA(A/ G/T)GG(T/ C)TT(A/ G)ATNCC-3' 
(corresponding to amino acid sequence 138-143). Reverse 
transcription (RT)-coupled PCR was performed as de- 
scribed previously [15]. The purified PCR product was cut 
with SalI and NotI on both ends, ligated into SalI- and 
Nod-cut pSPORT1 (GIBCO BRL, Life Technologies, 
Gaithersburg, MD), and transformed into Escherichia coli 
DH5a competent cells (GIBCO). Both strands of the 
subcloned cDNA inserts were sequenced by the chain- 
termination method with a Sequenase version 2.0 DNA 
sequencing kit (United States Biochemical, Cleveland, 
OH). An oligo(dT)-primed irectional rat kidney cDNA 
library was constructed in the SalI-NotI site of hgt22A 
(Superscript cDNA synthesis kit, GIBCO) and screened 
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-160 CTGAGGCTC'GCAGCTACTGAAACTC'ACACACACAGGGTTAAAC CT %~I'~TGTGC'CCATC CTCCTC CC CCTAGT 
CC CCCT~ACTGTAGGCTC,  GCAC, CAGTCCTAACTGCCTACTGAAC, CCA~TC, CTTGAGGAC, AGAGAGAGT~ C ~CC 
1 ATC, AATCC%"I~CAGAAAAATGAGTC CAA GGA~CC,~-r~-ITI-I~ACC TGTCTCTACTC, AGGAGATGCTGCCTAGACCTCC ~ 
1 M N P F Q K N E S K E T L F S P V S T E E M L P R P P S 
v 
85 CC~CAAAC, AAGTCACCTCCC, AAAATCTTTGGCTCCAGCTACCCAGTCAGCATTGCC~FFCATCGTGGTC~TC, AA %~'C TG CGAG 
29 P P K K S P P K I F G S • Y P V S I A F I V V N E F C E 
169 CGA~'I~C CTATTATGC.CATGAAAGCTGTGC ~ACC'FI~TAC TTC CTGTA TTTCCTGCA CTGGAATC.AAGACACGTCC A CTCT 
57 R F S Y Y G M K A V L T L Y F L Y F L H W N E D T S T S 
253 GTCTACCA TC, CC TTCAGCAGCC%~CTC, TA "FI'rCACTCCCA%~CTTC~T~CGGCC ATTGCTC, AC TCC TGGCTGC, GA~TTCAAG 
85 V Y H A F S S L C Y F T P I L G A A I A D S W L G K F K 
337 ACAATCATCTATC~TCCC~GTCTATGT~'I~GGCCA~GTAT'fCAAGTC %~r~TGC CATACCAATAC TGGC, A G G ~  
113 T I I Y L S L V Y V L G H V F K S L G A I P I L G G K M 
421 CTACATACAATC TTATCATTC, GTTGGTCTGAGTCTAATTGCTCTGGGAACAGGAGGTATCAAA C CC TGTG TGGCAGC~ 
141 L H T I L S L V G L S L I A L G T G G I K P C V A A F G 
505 GG~GACCAGT'~GAGGAACATGCAGAGC.CACGGACTAGATAC TTCT AGTC TTC TAC C TCGCCATCAATGCGGGGAGC~ 
169 G D Q F E E E H A E A R T R Y F S V F Y L A I N A G g L 
589 A~'fTC CACGTTCATCACAC CATC~GAGGAGATG~G'~C CAAGACTC, CTATGCACTGGC I"TTTGGAGT'~ CA 
197 I S T F I T P M L R G D V K C F G Q D C Y A L A F G V P 
673 GGA ~' I~TCAT~CTT~TGTTTGCAATGG~GCAAGATGTACAGGAAAC CAC CTCC TGAAGGGAACATAG ~ 
225 G L L M V L A L V V F A M G S K M Y R K P P P E G N I V 
757 GCTCAAGTTATCAAATC, ATA TGG~'rTGCTCTCT~CAACC GCTTCAGGAACC GTTC TGGGGACC ~CCGAAGC~C~ 
253 A Q V I K C I W F A L C N R F R N R S G D L P K R Q H W 
641 CTAGAC~C,  CAGAAAAATATCCAAAGCATCTCATCGCAGATGTGAAGGCC CTGAC CAGGGTACTGT~F?TA TATCCCA 
281 L D W A A E K Y P K H L I A D V K A L T R V L F L Y I P 
925 C TGCC CA "~TGC,  GCAC TTT~C CAACAGGGCTCGCGGTGGACTCTGCAAGCTAACAAGATGAA TG TGAC%~X~GG%~I'I~ 
309 L P M F W A L L D Q Q G S R W T L Q A N K M N G D L G F 
1009 TTTGTAC~i~TCAGCCGGATCAGATGCAGGTGCTAAATCCcTTTCTGGTTCTTATCq~TCATCcCCTTGTTTC~ACC~CA~AC 
337 F V L Q P D Q M Q V L N P F L V L I F I P L F D L V I ¥ 
1093 CGGCq~ATCTCCAAGTGCAGAATTAACTTCTCATCACTCAGGAAAATGGC G"FI~TATGA TC CTAGCG~' IT I - IG~ 
365 R L I S K C R I N F S S L R K M A V G M I L A C L A F A 
A 
1177 G~rGCAGCAC TTGTCGAGACA~TAAATC~TC,  ATCCATC CCCAGC C AGCTTCCCAAGAGATA'FFLT~CAAGTC "F~GAAT 
393 V A A L V E T K I N G M I a p Q P A S Q E I F L Q V L N 
1261 ~F I~AGATGGT~TGTAAAGGTGACCG TGCTGGGCAGTAC.AAATAATTC TC %' fGGTGGAGTCCGTCAGCTCT~A~C 
421 L A D G D V K V T V L G S R ~ N N S L L V E S V S S F Q N 
1345 ACAACGCACTATTCAAAAC TACACCTGGAGC, AAAGAGCCAAGATTTACA ~'FITCATCTGAAGTATAACAGCT~TC TGTCCAC 
449 T T H Y S K L M L E A K S Q D L H F H L K Y N S L S V H 
1429 AATGACCA~'PCTGTAC, AGGAGAAGAACTGTrACCAGCTGC~CA ffI~-ACCAGGAC GGG~GAGTATCTCCAG~C ~ G  
477 N D H S V E E K N C Y Q L L I H Q D G E S I S S M L V K 
1513 GATACAGGAATCAAACCAGCCAATGGGATGGCAGC T AGGT~TATTAACACT~CATAAAGAC~TGAACA TC TCC TTGGAT 
505 D T G I K P A N G M A A I R F I N T L H K D L N I S L D 
* 
1597 ACAGACGC TCCTCTCAGCGT~AAAGA CTACGGAGTGTCTGCATACAGAACTGTGCTAAGAGGAAAGTATC C~ AG~AC 
533 T D A P L S V G K D Y G V S A Y R T V L R G K Y P A V H 
1681 TGTGAAACTGAAGA CAAAGTCT~TCTCGATITAGG TC AAC TAGACTTTGGTACAACATAT~TTCGTGA TCAC TAATATC 
561 C E T E D K V F S L D L G Q L D F G T T Y L F V I T N I 
1765 AC CAGTCAGGGTCTTCAGGCCTGGAAGC, CAGAGGAC ATTC CA GTCAATAAACTA TCCAT~CA TGGCAGCTAC ACA GTA TG TC 
589 T S Q G L Q A W K A E D I P V N K L S I A W Q L P Q Y V 
1849 CTC~ACAGCAGCAGAGGTCATG~'rCTCAGTC ACAGGAC TTGAA ~I'I~TTATTCTCAGGCAC CA%~CTAC, ATGAAATC TG~ 
617 L V T A A E V M F S V T G L E F S Y S Q A P S S M K S V 
1933 CT~CAGGCGGCCTGGT~GTTGACC GTTGCAG~r~AATATCA ~'TGTGC TTGTCGTGGC TCAGTTC AGTC, GCCTGGCACAG~ 
645 L Q A A W L L T V A V G N I I V L V V A Q F S G L A Q W 
2017 GCCGAGTTCGT'~%'FI'rCCTGC CTCC TCCTC~CTGC CTGATC~'I~'TCCGTCATGG CCTAC TACTACG~TCC TCTAAAG 
673 A E F V L F S C L L L V V C L I F S V M A Y Y Y V P L K 
2101 TCAGAAGATACC GTGAGGCAACAC-ATAAGCAGATTC C'fGCCG TGCAGGG~TATGATTAACCTAGAAAC CAAGAATACAAGG 
701 S E D T R E A AT D K Q I P A V Q G N M I N L E T K N ~ T R 
2185 CTCTGA TC, AC ~I~,C TGATGGATA CCTGA CCC CTC~ TGA~FITCAGC CACTGC TTATTFrCAAGCAACA C CAT~CTCAG 
729 L * 
2269 GCCAGG%~fAGGAGAAGGAGACAGCATCTATC TGAATGGAT"~GCCTC CAGTTC C CTAC CA CAG TAGA~TA~ACT~G 
2353 ~'r'F~CAGATACATC"/'I~AAACAGGC, A%~CCGAGACTCCGTGCCCTACA GGCcG%~TCAAC %~GGTAAACGTCAGGTGA~ 
2437 CTCAGG CTGGCCCAGTATCTCCGAGTGCC CATC~TACAAATG TGTAGAAGAGATAAGTCTCACGG~T~ 
2521 GGGA %~fC  ~'ITAC CAGGTAT~ GC CTATAGC TCTACTTGTCGA TGTGTTGG' fTACAGAATACT~ CAAGT'FI~ ~ 
2605 ATCAGTCGTATAACTTCGCTATTCATGAGGA T TCAA~CGTTACATATAGTATGACCCAATCCAGAGC.CTAGCTTGTCAGC 
2689 TAGGAAGTCTAACATC, AT~AATAGA~I~GCAGACTATAC, AATGGCGT~TATCTACACATC, , AAGATA CC TCTTTTCTGAT'I~ 
2773 ACCACAG~TTTATCAACTTACC AACCAGGC~TCAGATCC~AAAAC CACAATTAAGGACAGTAGTCAGAA~G~ 
2857 GACACGGGGGTGCACATAAACTATTCA~'TC C GTACTACAC, GATACTAAAGAACTCTC CTGCTCCTGGCCTGGGCGTGCTCC 
2941 TCTGTC~CATCTGTCTAAC~CTAACTATAAC~C,  CAACC CAGGC TrTTC CGTC, G C C ~  CAG CTTAT~-~-~T~'D2AGT 
3025 GCATC~A~'rcTc, CGTATTACAGCAAGTCTTCAA T ACAAAATGTTCTTC TAACCCAACTTC TGT~'F*-~-*-~T*~ TA~A~ 
3109 TCCT'FI~'rATC, CATC~AL ~FL~'~C ~TAA' I -FFFL%~T' ITACAT~ CCT~TTAGCAGT'~T~TTTATTG~ 
5193 GGGATAATAC TAACATCCTAGGTCTGAAGCGCTAAACTGTGCTAGTCATCAAA TC~CAAGGAC TGCA TC, AGAAACTTA~ 
3277 AAA TCT~GAGG~CAGGTC,  CAGGTTTTGTTTGTGCGTGTC, AACAAAAGGAGTTGAGAGC, CAT'~TC ~ ~ T ~ T  
3361 AACGTC, GGTC AGGGGACGAG~' I~ T~TCAGGACTGTGTCATGTATTC CTAGGAGAAAACGT'fCCC~CC CTA TATG~G 
3445 ACCTCTCA~I'rCTGT~CTT~ACTACAC TG TTCCCT~CAACC, C,C CATGTT~TTGCACATTATTAGTAATGTAA T TATT CT 
3529 TAAC, CGAATC TGCTC CAGTTCGTCAAGCT~AAATACTTCAGTATTTAAGTAC CGAGATTTCAGAAAGCAT~AC A 
3613 ATA C CA TCTACTTTC CTCAGATGAC TTAATGAGAAC TGTC CAGACTCCT~AGAAGGTG'F~CACTTTCCAGAAGC~C 
3697 A~C~CT'~TC~T~A~GA~TTAACACTGATCTG~T~'FF~-F~' rACATACA~ 3778 
Fig. 1. Nucleotide and deduced amino acid sequence of rat PEPT2 cDNA. Potential N-linked glycosylation sites are indicated by asterisks. Potential 
protein kinase C phosphorylation sites (• )  and protein kinase A phosphorylation sites (9#) are indicated. The polyadenylation signal is boxed. 
H. Saito et al. / Biochimica et Biophysica Acta 1280 (1996) 173-177 175 
[15,18]. Positive clones were subcloned into SalI- and 
NotI-cut pSPORTI. The complete sequence was deter- 
mined on both strands using synthetic oligonucleotide 
primers. 5 ~g of poly(A)+RNA from tissues were re- 
solved by electrophoresis in 1% agarose gels containing 
formaldehyde and transferred on nylon membranes. Qual- 
ity of RNA was assessed by ethidium bromide staining. 
After transfer, blots were hybridized (50% formamide, 
5 X SSPE, 5 × Denhardt's solution, 0.2% SDS, 10 k~g/ml 
salmon sperm DNA at 42°C) with a whole rat PEPT2 
cDNA labeled with [c~-32p]dCTP. 10 ng of capped com- 
plementary RNA (cRNA) transcribed in vitro from NotI- 
linearized rat PEPTI or PEPT2 cDNA by use of T7 RNA 
polymerase were injected into Xenopus oocytes. Injected 
oocytes were maintained in modified Barth's medium at 
18°C for 2 days. Functional expression of rat PEPTI and 
PEPT2 was evaluated by measuring uptake of [3H]bestatin 
(12.7 GBq/mmol)  (Nippon Kayaku, Tokyo, Japan) in 
groups of oocytes injected with 50 nl of water or cRNA as 
described previously [15]. 
Two distinct PCR products were isolated by RT-PCR of 
the rat kidney cortex mRNA using degenerate primers 
designed on the amino acid sequence of rabbit PEPTI. 
One product showed = 80% nucleotide identity and an- 
other showed = 60% nucleotide identity to the rabbit 
PEPT1. Using these PCR products as a probe, a rat kidney 
Agt22A cDNA library was screened, and 3-kb and 4-kb 
clones, designated rat PEPTI [15] and rat PEPT2, respec- 
tively, were obtained. Sequencing of the insert revealed 
that the rat PEPT2 cDNA had 3938 bp, which encodes for 
a 729-amino acid protein of relative molecular mass of 81 
kDa with a poly(A) + tail (Fig. 1). The open reading frame 
ra t  PEPTI 
ra t  PEPT2 
ra t  PEPTI 
ra t  PEPT2 
ra t  PEPTI 
rat PEPT2 
ra t  PEPTI 
rat PEPT2 
rat PEPTI 
ra t  PEPT2 
rat PEPTI 
rat PEPT2 
ra t  PEPTI 
rat PEPT2 
ra t  PEPTI 
rat PEPT2 
ra t  PEPTI 
ra t  PEPT2 
ra t  PEPTI 
rat PEPT2 
1 MGMSK SRGCF~F IVVNEFC ERF S J 
1 MNPFQKNE SKETLF S PVSTEEML PR P PS P PKKS PPK I FGS YS[~A~ IVVNEFCERF S ~] 
- -  MI - -  
31 ~ ~ R A ~ D ~ A ~ V ~ ~ I A D S W L G K F K T  ~ V ~  
61 [YGMM~q_~ Lq~_Y_~L3~_~}[~q~q~_~ S __H~ S Ls~_C_~ T P I LG~ I AD S WL GK F KT ~ I ~ i ~ 
- - M 2 - -  
91 ~GQAV~VSgN~TDHDHDG S PNNL~V~M~L IALGTGG IKPC J~ 
121 ~GHVF~LG~ P ~L~ ........ GGKM LI~T L]L~ L~@ L IALGTGG I K PC~AFGGD ~ 
' - - -N3~ N4 - -  
151 ~ G Q E K ~  ~F YLA I NAG S q~ ~-~ ~VQQCG I H ~ Q ~ ~  
1"72 IFEBEHAE~FYLA I NAG S ~ SI~_~ IS~_T~M~ - GDVKC FG~D c~C_~A~AFGVP~3 L ~
230211 ~ ~ F ~ M G ~ I ~ K D ~ ~ D p  VA L G P 
271 E~ S Q ~ F L Y I  PL PMFWA~DQQGSRWTLQ~T~K~T I E ~ ~ A  
29O K~[~AD%~AI~ F  L Y I PL PMFWA~DQQG S RWT LQ~U~_~MA~DI~F FV~Q PDQMQVI~ P
117 . . . .  
35o T GMIHP 
- -  M8 - -  M9 - -  
391 SGNQVQ I ~ IGN~M~-  YFPG~IT . . . .  ~AQMS~DTFMTFDVDQLT- SINVS S ~ 
410 ASQE I FL ~Q_~_~LAD~VIt~VLGS~INSLLVES~S SFQkLT~THYSKLHLEAKSQDLHFHLK 
444 G S PGVTTV~E~PGHRH~VWG P- -NLYRWKDGLN~EK~ENG~V~NEMI~ 
47o YNS LSVHN[~S~EKNCYQ_~ I HQDGES I S SMLVKDTG ] ~ _ ~ ~ I  h~__~HKDL~ 
530 SLDTDAPL~L~GKDYG~RTVL~]_ q -M~PAVHCL~TEDKV~L~-LDLG D~q[~L~_~T 
rat PEPTI 
rat PEPT2 
rat PEPTI 
ra t  PEPT2 
rat PEPTI 
ra t  PEPT2 
587 NI~q~-~QA~KLS]L~~FSVTGLEFSYSQAP~MKSV ~ 
mlO 
646 ~I~L~WLLTVffqGNIIVq~__~QFSGLAQW/QWA~WLV_L~SqLLLW~S~JYY[~VPLKSEDT 
- - M l 1 "  M 1 2 - -  
681 EAQ~EDEKKKGVGKENPYSSLEPVSQTNM 7i0 
7o5 REAqL~KQIPAVQGNMINLETKNTRL 729 
rat PEPT1 
A.  , . , .A ,  . . ,  . . . . . . . .  . . . . . .  . , .AA  1 
v 
1 101 201 301 401 Sel 601 701710 
O rat PEPT2 
1 101 201 301 401 501 601 7@I 729 
AMINO ACID 
Fig 2 Comparison of deduced amino acid sequences (upper)  and hydrophobicity plots (bottom) o f  the rat PEPT I  and PEPT2 Amino  acid identities in the 
sequences are boxed. Putative membrane-spanning c~-helices are underlined. 
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was assigned by a stop codon and a Kozak consensus 
initiation sequence [19]. Overall amino acid identity was 
48% with the rat PEPT1 (Fig. 2). The Kyte-Doolittle 
hydropathy analysis [20] of rat PEPT2 indicated that the 
transporter has twelve putative membrane-spanning a- 
helices and four potential N-linked glycosylation sites 
(N-X-S/T) at a predicted large extracellular loop between 
c~-helices 9 and 10, exhibiting a high degree of topological 
similarity to the rabbit and rat PEPT1 (Fig. 2). Three 
potential protein kinase A phosphorylation sites [21] at 
serine position 33 and threonine positions 12 and 727, and 
three potential protein kinase C phosphorylation sites [21] 
at serine positions 376 and 640 and at threonine position 
708 were identified in the predicted intracellular domains. 
The rat PEPT2 showed 83% amino acid identity to the 
recently-cloned human PEPT2 consisted of 729 amino 
acids [22]. The protein kinase A phosphorylation sites at 
threonine positions 12 and 727 were conserved in the 
sequence of human PEPT2. Among three phosphorylation 
sites for protein kinase C, both the serine at 376 and 640 
were identified in the human PEPT2. 
The tissue distribution of rat PEPT2 mRNA transcripts 
was examined by Northern blot analysis of poly(A) + RNA 
extracted from each of several rat tissues, using the full- 
length rat PEPT2 eDNA as a probe. A = 4-kb mRNA 
corresponding to the full-length rat PEPT2 eDNA was 
expressed predominantly in the kidney, especially in the 
medulla (Fig. 3). It has been reported that the human 
PEPT2 mRNA expression in the kidney was failed to 
detect by Northern blot analysis, but was specifically 
detected in the kidney by RT-PCR using specific primers 
for the human PEPT2 eDNA [22,23]. In rats, a = 4-kb 
band corresponding to the rat PEPT2 mRNA was also 
detected in the brain, lung and spleen, but was unde- 
tectable in the heart, liver and small intestine. We found 
that rat PEPT1 mRNA is expressed in both the small 
intestine and kidney [15], indicating a marked ifference in 
tissue distribution between rat PEPT1 and PEPT2. 
kb 
4.4- 
2.4- 
1.4- 
Fig. 3. Northern blot analysis of rat PEPT2 mRNA in rat tissues. 5 /xg of 
poly(A) ÷ RNA from the indicated tissues was run in lane and hybridized 
using the full-length rat PEPT2 eDNA under high stringency. 
30 I~1 pH 7.2 
pH 6.0 
kl, 
D~ 
0 - 
WATER PEPT1 PEPT2 
Fig. 4. Uptake of [3H]bestatin by oocytes injected with water or in vitro 
transcribed rat PEPTI or PEPT2 cRNA. Uptake by oocytes was assayed 
for 2 h at 25°C in the presence of 30 /xM [3H]bestatin 2 days after 
injection of 50 nl of water or cRNA (10 ng). Each column represents he 
mean + S.E. of four experiments. Four oocytes were used for each uptake 
experiment. 
When expressed in Xenopus oocytes, both rat PEPT1 
and PEPT2 stimulated the uptake of [3H]bestatin, a nonme- 
tabolizable dipeptide-like drug, remarkably in the presence 
of an inward H + gradient (Fig. 4). The H +-gradient depen- 
dent uptake of [3H]bestatin i to oocytes injected with rat 
PEPT2 cRNA was much greater than that with rat PEPTI 
cRNA, indicating that rat PEPT2 has higher transport 
activity for bestatin than rat PEPTI. More recently, it was 
reported that there are differences between the human 
PEPT1 and PEPT2 in the recognition of fl-lactam antibi- 
otics [23], and that the PEPT2 possesses higher affinity 
than PEPT1 for diverse dipeptides [24]. 
We have found that the rat PEPT1 is expressed in the 
brush-border membranes of both the small intestine and 
kidney cortex by Western blot analysis using specific 
antibody against C-terminal peptide of rat PEPT1 protein 
[15]. In the kidney, small peptides generated by brush- 
border peptidases and filtered through glomerulus are effi- 
ciently reabsorbed via the peptide transport systems. More- 
over, a variety of oral /3-1actam antibiotics and bestatin can 
also be recognized by the peptide transporter and reab- 
sorbed from the tubular fluid, and thereby the transporter 
contributing renal handling of these drugs [6,7]. The pre- 
sent finding that the rat PEPT2 is predominantly expressed 
in the kidney medulla suggests that the transporter as well 
as the PEPTI plays a key role in both the maintenance of
protein nutrition and therapeutic efficacy of peptide-like 
drugs. Therefore, further studies on functional charac- 
terization and intrarenal ocalization of the PEPT1 and 
PEPT2 will enable comparison of their physiological and 
pharmacological significance in the kidney. Alternatively, 
in the brain, lung and spleen which appeared to express the 
PEPT2 mRNA, the transporter may participate in unrecog- 
nized physiological function(s) related to active transport 
of small peptides across plasma membranes of these tis- 
sues. It has been reported that di- and tripeptides can be 
transported across the epithelium of lung [25], suggesting 
the expression of peptide transport system. 
H. Saito et a l . /  Biochimica et Biophysica Acta 1280 (1996) 173-177 177 
In conclusion, a cDNA encoding rat H+-coupled pep- 
tide transporter PEPT2 was isolated. Northern blot analysis 
revealed that the PEPT2 mRNA is expressed predomi- 
nantly in the kidney, especially in medulla compared to 
cortex, and also in the brain, lung and spleen, but not in 
the small intestine. 
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